RANI - Canaccord believes Rani restructuring will help speed development
2023-11-03 17:23:29 ET
More on Rani Therapeutics
- Rani Therapeutics: Excellent Technology But Major Risks Ahead
- Rani to cut 25% of workforce as it reprioritizes drug programs
- Seeking Alpha’s Quant Rating on Rani Therapeutics
- Historical earnings data for Rani Therapeutics
- Financial information for Rani Therapeutics
For further details see:
Canaccord believes Rani restructuring will help speed development